Clinical Trial: ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)

U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07565467) titled 'ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)' on April 27.

Brief Summary: To help people with high-risk cancer variants to follow cancer surveillance guidelines and lower their risk of developing the disease.

Study Start Date: Oct. 08, 2026

Study Type: INTERVENTIONAL

Condition: ACT-GEN Genetic Cancer Syndromes

Intervention: OTHER: Standard of care

Standard of Care, no efforts will be made toward any of the study objectives

OTHER: Interviews

Up to three interviews may be conducted per participant, and they may take place remotely via a secure videoconferencing service to limit disruptions to the participan...